Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://majannbx140011.arwebo.com/61304716/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements